BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 82928)

  • 1. Comparison of the adjuvant effect of three BCG preparations in mice.
    Baker MA; Taub RN
    Oncology; 1978; 35(5):214-6. PubMed ID: 82928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice.
    Derrick SC; Yang A; Parra M; Kolibab K; Morris SL
    Vaccine; 2015 Jan; 33(1):126-32. PubMed ID: 25448108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of different strains of BCG vaccine in mice: T-cell dependent immune responses.
    Lagrange PH
    Dev Biol Stand; 1977 Apr 13-15; 38():223-9. PubMed ID: 415920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunologic and immunotherapeutic sequelae of intraperitoneal BCG. II: Serial changes in spleen weight, morphology, cell populations and in vitro mitogen responses.
    Roche WR; McLaughlin H
    Ir J Med Sci; 1983 Aug; 152(8):307-10. PubMed ID: 6629706
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of BCG on lymphocyte trapping.
    Zatz MM
    J Immunol; 1976 Jun; 116(6):1587-91. PubMed ID: 774988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of BCG vaccine on neoplastic proliferation and host immune responses.
    Hakim AA; Grand NG
    J Pharm Sci; 1976 Mar; 65(3):339-43. PubMed ID: 1263078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of immunosuppressive drugs and immunostimulating agents on reproductive performance.
    Scott JR
    Transplant Proc; 1977 Jun; 9(2):1403-7. PubMed ID: 878011
    [No Abstract]   [Full Text] [Related]  

  • 8. Augmentation of immunity of line 10 hepatoma by BCG: comparison of different BCG preparations.
    Bartlett GL; Kreider JW; Purnell DM; Katsilas DC
    Cancer; 1980 Aug; 46(3):488-96. PubMed ID: 6994867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of BCG-induced reactions of T and B areas in peripheral lymphoid organs of young adult BALB/c mice. A histomorphometrical and autoradiographical study.
    Meyer EM; Wilsmann K; Schlake W; Grundmann E
    Pathol Res Pract; 1979 May; 164(2):127-40. PubMed ID: 313564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Spleen reactivity after BCG treatement: test and strain dependency of the response].
    Florentin I; Orbach-Arbouys S
    Ann Immunol (Paris); 1977; 128(1-2):271-2. PubMed ID: 15497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG-induced changes in size of thymic cortex and thymus-dependent areas in spleen and lymph nodes of mice.
    Meyer EM; Grundmann E
    Clin Exp Immunol; 1980 Jan; 39(1):60-5. PubMed ID: 7389199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence.
    Taub RN; Gershon RK
    J Immunol; 1972 Feb; 108(2):377-86. PubMed ID: 4114954
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization of mice after airborne infection with various strains of BCG.
    Lefford MJ
    Am Rev Respir Dis; 1978 Jan; 117(1):103-9. PubMed ID: 339795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
    Mellow L; Sabbadini E
    Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IMMUNOGENICITY AND PROTECTIVE EFFICIENCY OF BCG IN COMBINATION WITH DNA VACCINE IN A MURINE TUBERCULOSIS MODEL].
    Tuberk Biolezni Legkih; 2010; (3):38-40. PubMed ID: 27529957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c).
    Hwang SA; Arora R; Kruzel ML; Actor JK
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S49-54. PubMed ID: 20006305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New immunological approaches to the application of BCG vaccine for the treatments of tumors (acute leukoses).
    Ter-Grigorov VS; Yablokova TB; Levy DT; Rosenberg AM; Pisarenko NN; Levewbook IS; Graff IA
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):25-31. PubMed ID: 57195
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid adjuvant enhanced the immunogenicity of a Mycobacterium tuberculosis subunit vaccine].
    Song NN; Wang BX; Shi DZ; Fu LF; Luo Y; Yu HJ; Han SB; Jiao L; Qie YQ; Wang HH; Zhang Y; Zhu BD
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):513-6. PubMed ID: 19954005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.